earnings call

By Mallory Hackett 12:44 pm July 31, 2020
Dexcom President and CEO Kevin Sayer is “incredibly proud” of what the company is calling “resilient growth” in the second quarter of 2020, according to an earnings call on Tuesday. Despite having some uncertainty in the impacts of the COVID-19 pandemic, Dexcom was able to produce significant year-over-year growth in Q2 2020. Sayer attributes much of the growth to a steady increase in knowledge...
By Dave Muoio 01:29 pm July 30, 2020
Teladoc Health continues its strong upward trend during its second fiscal quarter, with CEO Jason Gorevic informing investors yesterday that the company had outperformed "all key financial and operation metrics." Similar to the first quarter, the telehealth company is touting massive year-over-year (YoY) growth in revenue, visit volume and new registrations, as well as the acquisition of several...
By Laura Lovett 03:17 pm May 21, 2020
One Medical, the tech enabled health startup that made headlines when it went public in January, is reporting a 25% year-over-year revenue growth. However, it still came up short of meeting earnings per share expectations. The company, officially named 1Life Healthcare, uses a hybrid model, its members have access to 24-7 virtual health-services as well as the ability to visit brick-and-mortar...
By MobiHealthNews 03:23 pm May 8, 2020
This quarter Dexcom raked in $405 million in revenue, compared to $280.5 million in 2019’s Q1. This represents a 44% increase year over year (YoY), and beats the company's revenue goal by $46.7 million. Dexcom attributes its success to its growing user rate. The gross profits from Q1 were $258.7 million. However, operating expenses have increased, coming in at $215.4 million in 2020 Q1, versus $...
By Dave Muoio 02:26 pm March 3, 2020
It was another strong quarter for the ever-growing Livongo Health, which yesterday reported to investors a 137% rise in year-over-year Q4 revenue from $21.2 million to $50.2 million. Full-year revenues followed a similar path, growing 149% from $68.4 million in 2018 to $169.9 million in 2019. “Livongo finished the year with excellent momentum, exceeding all of our guidance metrics, achieving...
By Dave Muoio 03:00 pm February 28, 2020
The year 2019 was good to Teladoc Health. Although still operating at a loss, the virtual care provider enters the new year hot with reports that revenue and visits — domestic and international, paid membership and visit fee — all outpaced the company’s projections. Teladoc said during a Wednesday afternoon earnings call that it is expecting that growth to continue. Part of this is due to the...
By Dave Muoio 02:33 pm November 7, 2019
Fitbit’s year-over-year device sales flatlined in Q3 2019, which combined with lower sales tag prices drove a decline in revenue, according to the wearables maker’s latest quarterly earnings. The reporting — which was bereft of an investor’s call, Q&A and any forward-looking statements due to the company’s pending acquisition — is the latest look at a wearables business Google apparently...
By Dave Muoio 03:32 pm October 31, 2019
Apple's high on health. Apple CEO Tim Cook was pleased as punch with his company’s latest quarterly and yearly report, which he said on an investor’s call yesterday was Apple’s “highest revenue in a September quarter ever” at $64 billion. Thirty-three million dollars of this was in iPhone revenue — a 9% decline over last year that he felt was a significant step up from the 15% decline seen...
By Laura Lovett 03:33 pm August 9, 2019
Fitbit’s latest earnings call was a mixed bag for the wearable giant. The company’s revenue and device sales were up; however, the average price of the devices was down. This has led to the company to lower its revenue guidance by $95 million.  It appears to be continuing to focus in on its health division, which is seeing an uptick in year-over-year revenue, and is on track to meet its $100...
By Jonah Comstock 03:04 pm August 9, 2019
In Dexcom’s latest earnings report, executives reported not only growing revenues and sales volume for the company, but a sense that the whole category of CGMs has arrived and is transforming diabetes care for the better, noting trends observed at the recent annual meeting of the American Diabetes Association. “We have been on record for years telling that the future is ‘CGM First’ and we believe...